Congratulations to the 2022 LiONS LAIR winners, who collected $50,000.  Innovation Factory’s LiONS LAIR event showcases the region’s innovative start-up community and gives up-and-coming entrepreneurs the opportunity to pitch their business to a panel of Hamilton’s top business experts and potential investors. Second place winner Shawn Mondoux, CEO of Llif Healthcare received $15,000 cash for […]

0 comments / 0 votes
0 comments / 0 votes

VoxNeuro Inc., a Hamilton-based commercial stage Software-as-a-Medical-Device (SaMD) brain health company that analyzes brain biomarkers to assess cognitive function, announced a new partnership with Boston University (“BU”), a world-class institution and private research university at the forefront of neuroscience and neurotechnology. In partnership with BU, VoxNeuro has launched two studies that will evaluate its cognitive […]

0 comments / 0 votes
0 comments / 0 votes

Making a smart site selection could drive the commercialisation of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialisation. Three areas in particular, are making site selection easier: innovation parks, clinical infrastructure and supportive networks. Business location is a massive factor […]

0 comments / 0 votes
0 comments / 0 votes

Lactiga Therapeutics, an early-stage biotechnology company focused on improving the quality of life of patients with primary immunodeficiency diseases, announced this week that it has oversubscribed its pre-seed financing, raising $1.6 million in new capital including over $350,000 in research grants. The lead investor in the financing was 1517 Fund, and other investors include several […]

0 comments / 0 votes
0 comments / 0 votes

Adapsyn Bioscience Inc., a chemical bioinformatics company that discovers novel drug-like small molecules, today announced a strategic collaboration with Evotec SE. Under the collaboration, Evotec will have the opportunity to evaluate small molecules developed by Adapsyn as potential therapeutic candidates in proprietary and partnered drug discovery projects. The Adapsyn platform uses artificial intelligence and machine […]

0 comments / 0 votes
0 comments / 0 votes

Thursday, October 6, 2022, from 10:00 am to 12:00 pm in Hamilton, Ontario Mitchel Sivilotti, President of OmniaBio, and Dr. Michael May, President and CEO of CCRM, invite you to attend OmniaBio’s groundbreaking and signing ceremony. OmniaBio will be Canada’s first and largest commercial-scale contract development and manufacturing organization (CDMO) dedicated to cell and gene therapies. […]

0 comments / 0 votes

Archives

> <
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec